Apple launched the Apple Health AI Usage Study in the United States on 15 November, opening a virtual study with OpenEvidence to up to 200,000 eligible adults, according to Apple’s announcement. Through an associated app, the company plans to examine how people use and understand conversational health AI, and what influences their trust in its answers.
Key points
- The US study is open to up to 200,000 eligible people aged 21 or older.
- Participants need an Apple Intelligence-enabled iPhone running iOS 26 or later.
- OpenEvidence supplies the clinical AI technology for Apple’s research app.
- Apple says participants choose whether to share HealthKit data and that study data will not train AI models.
Apple studies trust and everyday health decisions
Apple says the study is designed to examine the quality of AI responses, whether users understand them and how they engage with the tool in daily life. It also aims to investigate whether health AI can help people prepare for appointments with their own doctors. Apple intends to use the findings to inform the design of health AI experiences for itself and the wider industry.
The questions reach beyond whether the app can produce an answer. Apple says it wants to understand what earns users’ trust and whether information presented through the app relates to everyday health actions. Sumbul Desai, Apple’s vice president of Health and Fitness, described the dedicated study as a way to examine how people evaluate health AI in ordinary use.
Apple says consumer tools powered by large language models can give answers that are incomplete or difficult to understand. Its study therefore includes comprehension alongside response quality. The research app allows participants to ask routine health questions and read explanations of more complex medical information.
OpenEvidence supplies answers with clinical citations
OpenEvidence is a clinical AI platform used by healthcare professionals. Apple says it produces answers from medical material including The New England Journal of Medicine, the Journal of the American Medical Association and Nature. In the study, OpenEvidence’s technology sits inside a research experience designed by Apple.
Participants can view links to peer-reviewed clinical material alongside responses, Apple says. They can also choose to bring personal health information into their questions, allowing the study to examine whether that information changes the relevance of an answer or the user’s understanding of it.
The collaboration gives OpenEvidence another route into consumer-facing medical AI research. AI Affairs previously reported that OpenEvidence and Anthropic offered free medical AI in around 100 countries. Apple’s announcement describes this arrangement as a research study centred on how consumers use a health AI app.
Robert M. Wachter, professor and chair of the Department of Medicine at UCSF, said patients and clinicians are turning to AI tools developed and tested in different settings. He said studying how people use related tools could help patients prepare for conversations with their doctors.
HealthKit sharing remains a participant choice
Enrolment is available across the United States to eligible adults aged at least 21. Apple says joining requires an Apple Intelligence-enabled iPhone — an iPhone 15 Pro or later — running iOS 26 or later. Prospective participants can download the study app to review the research and choose whether to enrol.
Participants decide whether to share HealthKit information, Apple says. The available types include resting heart rate, activity, sleep and lab results. They also control whether to share survey responses. Apple says it has put security measures in place for the study data it holds and for participants’ confidentiality.
Apple says study data will not be used to train AI models. The app also has safeguards intended to recognise certain concerning questions and suggest that a participant contact a healthcare provider or another resource. Apple says the app is not intended to diagnose or treat a condition or replace medical advice, and advises participants to consult a clinician about health concerns or to check medical information.